Log in

POCI PRECISION OPTICS CORPORATION, INC. NASDAQ · United States

PRECISION OPTICS CORPORATION, INC. (POCI) news

PRECISION OPTICS CORPORATION, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker POCI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest PRECISION OPTICS CORPORATION, INC. news

We have not published a story on PRECISION OPTICS CORPORATION, INC. yet. When there is news, it will appear here.

What PRECISION OPTICS CORPORATION, INC. does

Precision Optics Corporation, Inc. has been a developer and manufacturer of advanced optical instruments since 1982. It operates primarily in two market segments, medical devices and advanced defense and aerospace products. It designs and manufactures ultra-high precision endoscopes, digital imaging endoscopes using CMOS sensor technology, and very small Microprecision lenses, assemblies and complete medical devices for minimally invasive surgery. For defense and aerospace, it applies its optical technologies to applications including satellite network communications. Its business is conducted through systems manufacturing, engineering and product development, Ross Optical components and assemblies, and a micro-optics laboratory. The company acquired the operating assets of Ross Optical Industries, Inc. of El Paso, Texas, effective June 1, 2019, and the operating assets of Lighthouse Imaging, LLC of Windham, Maine, effective October 1, 2021, to expand its optics components and electrical engineering capabilities.

Product or programWhat it isStage
Endoscopes and Microprecision medical devicesUltra-high precision endoscopes and small lenses for minimally invasive surgery
Ross Optical components and assembliesCustom optical components and assemblies for military, defense and industrial customers
Defense and aerospace opticsOptical technologies for defense and aerospace, including satellite network communications

Summarised from the company's 10-K filed Sep 28, 2026.

PRECISION OPTICS CORPORATION, INC. annual financials

LineFY ended Jun 30, 2026FY ended Jun 30, 2025
Revenue$31.5 million$19.1 million
Research and development$1.0 million$1.2 million
Net income (loss)-$3.6 million-$5.8 million
Cash from operations-$1.6 million-$3.4 million
Cash and equivalents$9.8 million$1.8 million

Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $9.8 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about PRECISION OPTICS CORPORATION, INC.

What is the ticker symbol of PRECISION OPTICS CORPORATION, INC.?

PRECISION OPTICS CORPORATION, INC. trades under the ticker POCI on NASDAQ.

Where is PRECISION OPTICS CORPORATION, INC. listed?

PRECISION OPTICS CORPORATION, INC. is listed on NASDAQ.

Which country or territory is PRECISION OPTICS CORPORATION, INC. listed under?

Our directory records PRECISION OPTICS CORPORATION, INC. under United States.

Does aibio.space cover PRECISION OPTICS CORPORATION, INC.?

aibio.space lists PRECISION OPTICS CORPORATION, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

What does PRECISION OPTICS CORPORATION, INC. develop?

Precision Optics Corporation, Inc. has been a developer and manufacturer of advanced optical instruments since 1982. It operates primarily in two market segments, medical devices and advanced defense and aerospace products.

What is Endoscopes and Microprecision medical devices from PRECISION OPTICS CORPORATION, INC.?

Endoscopes and Microprecision medical devices: Ultra-high precision endoscopes and small lenses for minimally invasive surgery Stage: not stated.

What is Ross Optical components and assemblies from PRECISION OPTICS CORPORATION, INC.?

Ross Optical components and assemblies: Custom optical components and assemblies for military, defense and industrial customers Stage: not stated.

What was PRECISION OPTICS CORPORATION, INC.'s revenue last year?

$31.5 million for the fiscal year ended Jun 30, 2026, as reported to the SEC.

Is PRECISION OPTICS CORPORATION, INC. profitable?

PRECISION OPTICS CORPORATION, INC. reported a net loss of $3.6 million for the fiscal year ended Jun 30, 2026, and used $1.6 million of cash in operations, per its annual report to the SEC.

How much does PRECISION OPTICS CORPORATION, INC. spend on research and development?

$1.0 million in the fiscal year ended Jun 30, 2026, per its annual report.

How much cash does PRECISION OPTICS CORPORATION, INC. have?

$9.8 million in cash at Jun 30, 2026, per its 10-K.

Investor discussion: PRECISION OPTICS CORPORATION, INC.

Members talk about PRECISION OPTICS CORPORATION, INC. (POCI). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:POCI on TradingView.

Listing details

PRECISION OPTICS CORPORATION, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker POCI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
PRECISION OPTICS CORPORATION, INC.
Ticker
POCI
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.